Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital

Protein phosphatase, Mg2+/Mn2+-dependent 1D (PPM1D) mutations in haematological cancer

Publikation: Bidrag til tidsskriftReviewForskningpeer review


  1. Doing less, accomplishing more for childhood ALL: response

    Publikation: Bidrag til tidsskriftLetterForskningpeer review

  2. TET2 deficiency cooperates with CBFB-MYH11 to induce acute myeloid leukaemia and represents an early leukaemogenic event

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Obesity as a predictor of treatment-related toxicity in children with acute lymphoblastic leukaemia

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Chronic lymphocytic leukaemia clones are detectable decades before diagnosis

    Publikation: Bidrag til tidsskriftLetterForskningpeer review

Vis graf over relationer

Until recently, the protein phosphatase, Mg2+/Mn2+-dependent 1D (PPM1D) gene had not been examined in haematological cancer, but several studies have now explored the functional role of this gene and its aberrations. It is often mutated in the context of clonal haemopoiesis (including in patients with lymphoma, myeloproliferative neoplasms and myelodysplastic syndrome) and mutations have been associated with exposure to cytotoxic and radiation therapy, development of therapy-related neoplasms and inferior survival. The vast majority of PPM1D mutations found in haematopoietic cells are of the nonsense or frameshift type and located within terminal exon 6. These genetic defects are rarely found in the blood of healthy individuals. PPM1D encodes the PPM1D phosphatase [also named wild-type p53-induced phosphatase 1 (WIP1)], which negatively regulates signalling molecules within the DNA damage response pathway, including tumour suppressor p53. Clonal expansion of PPM1D mutant haematopoietic cells can potentially be prevented with inhibitors; however, human trials are awaited. In the present review, we provide a review of the literature regarding PPM1D and its role in haematological cancer.

TidsskriftBritish Journal of Haematology
Udgave nummer4
Sider (fra-til)697-705
Antal sider9
StatusUdgivet - feb. 2021

ID: 62327419